News by subject: Share Issue

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of...

VICI Properties Inc. ("VICI Properties" or the "Company"), an experiential asset real estate investment trust, today announced the pricing of an underwritten public offering of 16,500,000 shares of its common stock subject to the forward sale...

ETF Managers Group, LLC (ETFMG) announced today that the Board of Trustees of the ETF Managers Trust has decided to close the ETFMG 2x Daily Inverse Alternative Harvest ETF (MJIN) based on an ongoing review of market demand. Effective immediately,...

Rocket Pharmaceuticals, Inc. , a leading late-stage, clinical biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need, today reports financial results for the...

Puma Biotechnology, Inc. , a biopharmaceutical company, announced that on November 1, 2022, the Compensation Committee of Puma's Board of Directors approved the grant of inducement restricted stock unit awards covering 7,250 shares of Puma common...

Texas Pacific Land Corporation (the "Company" or "TPL") today announced its financial and operating results for the third quarter of 2022. Third Quarter 2022 Highlights Net income of $129.8 million, or $16.83 per share (basic) and $16.82 per...

Quanergy Systems, Inc., ("Quanergy" or the "Company") a leading provider of LiDAR sensors and smart 3D solutions, today announced the closing of its previously announced underwritten public offering for gross proceeds of approximately $16.7 million...

Ligand Pharmaceuticals Incorporated today announced the completion of its expected tax-free distribution (Distribution) of 100% of Ligand's interest in its subsidiary OmniAb on a pro rata basis to Ligand shareholders of record as of October 26,...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on October 31, 2022 (the "Grant Date") under Adicet's 2022...

AENZA S.A.A. (the "Company") hereby informs that, on October 18, 2022, the Company received a letter (the "Notice") from the New York Stock Exchange (the "NYSE") notifying the Company that it is below criteria with respect to the average closing...

Acacia Research Corporation ("Acacia" or the "Company") and Starboard Value LP ("Starboard"), an investment adviser with a focused and fundamental approach to investing in publicly traded U.S. companies, today announced an agreement to streamline...

Quanergy Systems, Inc., ("Quanergy" or the "Company") a leading provider of LiDAR sensors and smart 3D solutions, today announced the pricing of an underwritten public offering for gross proceeds of approximately $16.7 million prior to deducting...

Altria Group, Inc. today reports our 2022 third-quarter and nine-months business results and narrows our guidance for 2022 full-year adjusted diluted earnings per share (EPS). "This is an exciting moment on our journey towards Moving Beyond...

NextGen Healthcare, Inc. , a leading provider of innovative, cloud-based healthcare technology solutions, today announced its intention to offer, subject to market and other conditions, $200,000,000 aggregate principal amount of convertible senior...

Impac Mortgage Holdings, Inc. (the "Company") today announced the completion of its previously announced offers to each holder of the Company's 9.375% Series B Cumulative Redeemable Preferred Stock, par value $0.01 per share ("Series B Preferred...

Canada Jetlines Operations Ltd. (NEO: CJET) ("Canada Jetlines" or the "Company") the new, all-Canadian, leisure airline, announces that it intends to undertake a non-brokered private placement with its new Chair, Brigitte Goersch, to raise from...

The InfraCap Equity Income Fund ETF (the "Fund" or "ICAP") has declared a monthly distribution of $0.175 per share ($2.10 per share on an annualized basis). The distribution will be paid on October 28, 2022, to shareholders of record as of the close...

Western Exploration Inc. (the "Corporation" or "Western Exploration") today announces that, in response to regulatory feedback, it has amended its notice of articles to change the identifying name of its outstanding class of shares from "Common...

W. R. Berkley Corporation today reported its third quarter 2022 results. Summary Financial Data   (Amounts in thousands, except per share data)     Third Quarter   Nine Months     2022       2021  ...

Soluna Holdings, Inc. ("SHI" or the "Company"), , the parent company of Soluna Computing, Inc. ("SCI"), a developer of green data centers for cryptocurrency mining and other intensive computing, today announced the pricing of its previously announced...

Corner Growth Acquisition Corp. 2 ("Corner Growth" or the "Company") today launched a fixed price tender offer (the "Tender Offer") to purchase and redeem its Class A Ordinary Shares (the "Shares") at a purchase price of $10.21 per share. On October...

Impac Mortgage Holdings, Inc. (the "Company") today announced that the holders of the Company's Common Stock, par value $0.01 per share ("Common Stock"), approved the proposals that were conditions to the closing of the previously announced offers...

Carlisle Companies Incorporated today announced a special stock option grant to all eligible U.S. employees and a cash award to all eligible employees outside the U.S., representing Carlisle's third broad-based stock option or cash equivalent grant...

Prosus N.V. (Prosus) (AEX and JSE: PRX): Shareholders are referred to the public statements made by Naspers Limited and Prosus (together with their subsidiaries and affiliates, the Group) on 24 March 2022 and 20 May 2022, and in the Prosus results...

Novo Integrated Sciences, Inc. (the "Company" or "Novo"), today announced the pricing of its public offering of an aggregate of 4,000,000 units at a public offering price of $0.50 per unit. Each unit consists of (i) one share of common stock (or one...

Impac Mortgage Holdings, Inc. (the "Company") today announced that the Company's Board of Directors determined that the Company will issue shares of the Company's 8.25% Series D Cumulative Redeemable Preferred Stock, par value $0.01 per share ("New...

Alternus Energy Group Plc ("Alternus" or the "Company") (OSE: ALT) and Clean Earth Acquisitions Corp. ("Clean Earth"), a climate technology and energy transition-focused special purpose acquisition company, today announced the execution of a...

Amylyx Pharmaceuticals, Inc. ("Amylyx") today announced the closing of its previously announced upsized underwritten public offering of 7,697,812 shares of its common stock at a public offering price of $32.00 per share, which includes the exercise...

Global Business Travel Group, Inc. (the "Company" or "Amex GBT") , the world's leading B2B travel platform, today announced the expiration and results of its previously announced exchange offer (the "Offer") and consent solicitation (the "Consent...

Regulatory News: Nanobiotix (Paris:NANO) : Market: Euronext Paris / Nasdaq Euronext Compartment: B ISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website: www.nanobiotix.com Date Number of Shares Outstanding  ...

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of 8,000 restricted...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to purchase 22,500 shares of its common stock and the grant of 15,000 restricted stock units...

InVivo Therapeutics Holdings Corp. , a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that it has entered into a definitive agreement with a single...

Amylyx Pharmaceuticals, Inc. ("Amylyx") today announced the pricing of an upsized underwritten public offering of 6,693,750 shares of its common stock at a public offering price of $32.00 per share. All of the shares of common stock are being...

Blue Apron today announced that it has completed its previously announced at-the-market equity offering program under which it sold shares of its Class A common stock for aggregate gross proceeds to the company of approximately $15 million. A total...

Amylyx Pharmaceuticals, Inc. ("Amylyx") today announced the launch of an underwritten public offering of 6,000,000 shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission ("SEC")....

Cian PLC ("Cian", the "Group" or the "Company"), a leading online real estate classifieds platform in Russia, announces the results of 2022 Annual General Meeting (the "AGM") held on September 30, 2022. As reflected in the voting results below, all...

Aurinia Pharmaceuticals Inc. (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, announced that the Company's Compensation Committee granted 4 new employees...

Adicet Bio, Inc. , a clinical-stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell therapies for cancer, today announced it granted inducement awards on September 30, 2022 (the "Grant Date") under Adicet's 2022...

voxeljet AG (WKN: A2QBGM / ISIN: US92912L2060) (the "Company", or "voxeljet"), a leading provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers, today announced that it has entered into...

voxeljet AG (WKN: A2QBGM / ISIN: US92912L2060) (the "Company", or "voxeljet") management board today approved, with the consent of the supervisory board, an increase in the company's registered share capital against cash contributions, under...

Gamida Cell Ltd. , the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced the launch of a follow-on public offering of its ordinary shares. In...

United Natural Foods, Inc. (the "Company" or "UNFI") today reported financial results for the fourth quarter (13 weeks) and fiscal year (52 weeks) ended July 30, 2022. Fiscal 2022 Full Year Highlights Net sales increased 7.3% to $28.9 billion...

Allianz Investment Management LLC (AllianzIM), a wholly-owned subsidiary of Allianz Life Insurance Company of North America (Allianz Life®), announced a ticker symbol change for eight existing AllianzIM Buffered Outcome ETFs effective on October 31,...

Vroom, Inc. , a leading e-commerce platform for buying and selling used vehicles, today reported that on September 22, 2022, the Compensation Committee of Vroom's Board of Directors approved the grant of inducement restricted stock unit awards...

Geron Corporation today reported that it has granted non-statutory stock options to purchase an aggregate of 901,950 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company....

Loop Media, Inc. ("Loop Media") , a leading multi-channel streaming platform that provides curated music video and branded entertainment channels for businesses and consumers, today announced the pricing of an underwritten public offering of...

WeCommerce Holdings Ltd. ("WeCommerce" or the "Company") today announced that the TSX Venture Exchange (the "Exchange") has accepted the Company's Notice of Intention to renew a normal course issuer bid ("NCIB"). Pursuant to the NCIB, WeCommerce...

Alpine Immune Sciences, Inc. , a clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced the pricing of its underwritten public offering of 13,606,000...

Aditxt, Inc., (the "Company" or "Aditxt"), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today announced the closing of its previously announced public offering of...